huntington's phase 3 - SERP Analysis

https://pmc.ncbi.nlm.nih.gov/articles/PMC10674993/

https://hdsa.org/hd-research/therapies-in-pipeline/

https://www.neurology.org/doi/10.1212/WNL.0000000000208206

https://www.nejm.org/doi/full/10.1056/NEJMc2300400

https://news.prilenia.com/press-releases/press-release-details/2023/Prilenia-Shares-Preliminary-Topline-Results-from-Phase-3-PROOF-HD-Clinical-Trial-in-Huntingtons-Disease-and-Data-from-Phase-2-HEALEY-ALS-Platform-Trial-of-Pridopidine-at-the-75th-American-Academy-of-Neurology-AAN-Annual-Meeting/default.aspx

https://en.hdbuzz.net/may-2025-this-month-in-huntingtons-disease-research/

https://neurocrine.gcs-web.com/news-releases/news-release-details/neurocrine-biosciences-announces-publication-full-kinecttm-hd

https://www.neurology.org/doi/10.1212/WNL.0000000000212224

https://go.drugbank.com/drugs/DB04844/clinical_trials?conditions=DBCOND0053941&phase=3&purpose=treatment&status=completed

https://ir.ionis.com/news-releases/news-release-details/ionis-partner-evaluate-tominersen-huntingtons-disease-new-phase

https://www.ucl.ac.uk/brain-sciences/news/2023/dec/analysis-drug-trial-renews-hope-future-huntingtons-disease-treatments

https://ir.ptcbio.com/news-releases/news-release-details/fda-grants-fast-track-designation-ptc518-huntingtons-disease

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00127-8/fulltext

https://www.fiercebiotech.com/biotech/roche-halts-huntington-s-phase-3-ionis-partnered-antisense-drug-after-interim-review

https://en.hdbuzz.net/402

https://huntingtonstudygroup.org/hd-insights/hd-research-clinical-trials-updates/

https://www.neurologylive.com/view/gene-therapy-amt-130-huntington-disease-progression-interim-phase-1-2-trials

https://hdsa.org/blog/hdbuzz-covers-new-huntingtin-lowering-strategy/

https://www.uniqure.com/programs-pipeline/huntingtons-disease

https://www.healio.com/news/neurology/20230331/phase-3-study-to-assess-safety-efficacy-of-huntingtons-disease-therapeutic-complete

https://www.biopharmadive.com/news/roche-huntington-tominersen-ionis-data-details/617518/

https://www.biospace.com/prilenia-s-phase-3-huntington-s-disease-clinical-trial-achieves-50-percent-enrollment

https://huntingtonstudygroup.org/clinical-research/proven-successes/

https://www.austedohcp.com/huntingtons-disease-chorea/3-year-study

https://huntington-disease.org/research/

https://huntingtonsdiseasenews.com/news/hdsa-2024-huntingtons-disease-clinical-trials-enrolling-us/

https://www.gene.com/media/press-releases/14902/2021-03-22/genentech-provides-update-on-tominersen-

https://patientworthy.com/2019/01/31/phase-3-trial-underway-huntingtons-disease/

https://www.neurologylive.com/view/valbenazine-positive-phase-3-results-treating-chorea-huntington-disease

https://ir.ionis.com/news-releases/news-release-details/ionis-pharmaceuticals-licenses-ionis-htt-rx-partner-following

https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(11)70233-2/fulltext

https://neurocrine.gcs-web.com/news-releases/news-release-details/neurocrine-biosciences-presents-phase-3-data-kinect-hd-study

https://hdcare.org/prilenia-achieves-last-patient-last-visit-in-phase-3-proof-hd-clinical-study-for-huntingtons-disease/

https://www.sciencedirect.com/science/article/pii/S1353802024000610?via=ihub

https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/hd/a-study-to-evaluate-the-safety--biomarkers--and-efficac-41200.html

https://content.iospress.com/articles/journal-of-huntingtons-disease/jhd240017

https://huntingtonsdiseasenews.com/news/aan-2023-pridopidine-phase-3-trial-benefits-some-patients/

https://www.hdyo.org/a/795-update-on-ptc-trial-pivot-hd

https://international-biopharma.com/roche-revives-a-closely-watched-huntingtons-disease-drug/

https://www.clinicalresearchnewsonline.com/news/2025/02/26/follow-the-money-rare-muscle-disease-treatment-huntington-s-disease-trial-more

https://journals.sagepub.com/doi/10.3233/JHD-239001

https://journals.lww.com/md-journal/fulltext/2024/12270/a_narrative_review_of_phase_iii_and_iv_clinical.60.aspx

https://www.drugtargetreview.com/news/154613/novartis-licenses-innovative-treatment-for-huntingtons-disease/

https://www.labiotech.eu/in-depth/huntingtons-disease-treatments/

https://patientworthy.com/2020/04/24/enrollment-completed-for-huntingtons-disease-trial/

https://www.oligotherapeutics.org/encouraging-progress-in-the-hunt-for-a-huntingtons-treatment/

https://touchneurology.com/neurodegenerative-diseases/journal-articles/pridopidine-topline-results-from-the-phase-iii-trial-proof-hd-for-the-treatment-of-huntingtons-disease/

https://jnnp.bmj.com/content/92/Suppl_1/A36.1

https://curehd.blogspot.com/2018/12/roche-announces-us-canada-sites-for.html

https://www.researchgate.net/publication/374965881_Huntington's_Disease_Drug_Development_A_Phase_3_Pipeline_Analysis

https://globalgenes.org/raredaily/neurocrine-reports-phase-3-data-evaluating-valbenazine-for-huntingtons-chorea/

https://huntington-disease.org/2023/03/28/prilenia-achieves-last-patient-last-visit-in-phase-3-proof-hd-clinical-study-for-huntingtons-disease/

https://hdcare.org/roche-phase-3-clinical-trial-for-huntingtons-disease-gene-silencing-drug-to-enroll-volunteers-early-2019/

https://go.drugbank.com/indications/DBCOND0053941/clinical_trials/DB12161?phase=3&status=completed

https://digital.sandiego.edu/cgi/viewcontent.cgi?article=1277&context=huntingtons

https://www.biopharmadive.com/news/roche-ionis-start-new-huntington-trial-tominersen/617253/

https://s202.q4cdn.com/210612175/files/doc_news/Prilenia-Enrolls-First-Subject-in-Europe-in-its-PROOF-HD-Phase-3-Clinical-Trial-for-Huntingtons-Disease-2021.pdf

https://hdtrialfinder.net/en/trial-news/

https://www.e-jmd.org/journal/view.php?number=529

https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.3341?af=R

https://www.biospace.com/prilenia-enrolls-first-patients-into-its-proof-hd-phase-3-clinical-trial-for-huntington-s-disease-in-the-united-states

https://journals.sagepub.com/doi/10.1177/18796397241293955?int.sj-full-text.similar-articles.1

https://www.fiercebiotech.com/biotech/ptc-crashes-win-novartis-partnered-huntingtons-drug-fails-convince-investors

https://www.vjneurology.com/video/23nq5ldylvi-proof-hd-phase-iii-trial-of-oral-s1r-agonist-pridopidine-for-the-treatment-of-huntingtons-disease/

https://ir.ptcbio.com/news-releases/news-release-details/interim-pivot-hd-results-demonstrate-evidence-favorable-cns

https://www.mdsabstracts.org/abstract/treatment-effect-sizes-of-once-daily-valbenazine-for-tardive-dyskinesia-and-for-chorea-associated-with-huntingtons-disease-a-post-hoc-analysis-of-phase-3-clinical-trial-data/

https://prilenia.com/what-is-huntingtons-disease/

https://www.pfizer.com/news/press-release/press-release-detail/pfizer_and_medivation_announce_results_from_phase_3_horizon_trial_of_dimebon_in_huntington_disease

https://firstwordpharma.com/story/1097525

https://www.oligotherapeutics.org/phase-iii-trial-of-aso-therapy-for-the-treatment-of-huntingtons-disease-halted/

https://www.clinicaltrialsregister.eu/ctr-search/search?query=Huntington%2BDisease&page=2

https://www.roche.com/media/releases/med-cor-2021-03-22b

https://practicalneurology.com/diseases-diagnoses/movement-disorders/clinical-trials-for-huntington-disease/31681/

https://www.hda.org.uk/news/huntingtin-lowering-trials-an-update-from-wave-and-roche/

https://www.clinicaltrialsarena.com/features/huntingtons-disease-endpoints/

https://today.uconn.edu/2017/12/uconn-health-huntingtons-disease-expert-optimistic-new-drug/

https://www.nejm.org/doi/full/10.1056/NEJMoa1900907

https://www.nature.com/articles/s41591-022-01919-8

https://www.goodrx.com/conditions/huntingtons-disease/future-treatments-clinical-trials?srsltid=AfmBOorHjhW63cgNne-ArCJJiPIXCL1RmTogjpdeL5Uj6LVkY-W-UoRV

https://www.aan.com/msa/Public/Events/AbstractDetails/55540

https://clinicaltrials.ucsf.edu/trial/NCT04120493

https://www.medscape.com/viewarticle/740692

https://www.urmc.rochester.edu/news/story/urmc-clinical-researchers-pave-the-way-for-new-huntingtons-drug

https://digital.sandiego.edu/huntingtons/274/?utm_source=digital.sandiego.edu%2Fhuntingtons%2F274&utm_medium=PDF&utm_campaign=PDFCoverPages

https://med.uth.edu/neurosciences/about-us/research/movement-disorders-research/

https://ctv.veeva.com/study/efficacy-and-safety-of-nestacell-r-in-huntingtons-disease

https://neurology.georgetown.edu/hdcerc/researchcenter-clinicaltrials/

http://www.huntington.be/images/Brochures/jhd2F20182F7-32Fjhd-7-3-jhd1890032Fjhd-7-jhd189003.pdf

https://www.researchgate.net/publication/379718703_Analyses_of_the_Phase_3_Trial_of_Pridopidine's_Outcome_on_Function_in_Huntington_Disease_PROOF-HD_Demonstrates_Efficacy_in_Participants_Without_Antidopaminergic_Medications_S30002

https://www.hopkinsmedicine.org/psychiatry/specialty-areas/huntingtons-disease/research

https://www.cardiff.ac.uk/huntingtons-disease-centre/research/current-clinical-studies

https://curehd.blogspot.com/2019/06/roche-restarts-redesigned-phase-3.html

https://www.youtube.com/watch?v=Jh3b-3SjTMs

https://www.nature.com/articles/nrneurol.2011.208

https://practicalneurology.com/news/proof-hd-trial-results-show-benefits-of-pridopidine-as-huntington-disease-treatment-in-those-not-taking-adms/2474032/

https://www.hdyo.org/a/829-update-from-wave

https://www.mdsabstracts.org/abstract/fifteen-years-of-clinical-trials-in-huntingtons-disease-too-many-clinical-trial-failures/

https://www.pharmavoice.com/news/huntingtons-disease-pipeline-roche-uniqure-ionis-drugs/726366/

https://www.mayoclinic.org/diseases-conditions/huntingtons-disease/symptoms-causes/syc-20356117